KSC (40mg/kg) enhanced markedly the antileukemic and immunopotentiating activities of T AK/L IL 2 therapy. The rate of life prolongation was 36%,and the cure rate of the leukemia mice was doubled.

• KSC（40mg/kg）对T－AK/L－IL－2的抗白血病作用有明显的增强效应，荷瘤小鼠细胞免疫功能进一步增强，生命延长率、长期存活率分别提高36%25和99.；9%25。